HUTCHMED (China) Limited (AIM:HCM)
225.00
-7.50 (-3.23%)
May 6, 2025, 8:40 AM GMT+1
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
277.96K GBP
Profits / Employee
16.64K GBP
Market Cap
1.99B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Genus | 3,500 |
Oxford Nanopore Technologies | 1,315 |
HUTCHMED (China) News
- 12 days ago - HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 - GlobeNewsWire
- 13 days ago - AIM Market Roundup: Catenai, Seeen, Hutchmed - The Armchair Trader
- 14 days ago - HUTCHMED Completes Enrollment for Phase II Trial of Savolitinib in Gastric Cancer | HCM stock news - GuruFocus
- 14 days ago - HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China - GlobeNewsWire
- 22 days ago - Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war - South China Morning Post
- 6 weeks ago - HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma - GlobeNewsWire
- 6 weeks ago - Intended Retirement of Independent Non-executive Directors and changes of composition of board committees - GlobeNewsWire
- 6 weeks ago - US pharma restrictions won't affect Hutchmed operations, says CEO - CNBC